– UK, Bristol – Indivior PLC (LON: INDV | NASDAQ: INDV) today announced the appointment of Dr. Keith Humphreys, OBE, PhD to its Board as an Independent Non-Executive Director with immediate effect.
“We are pleased to have Keith join Indivior’s Board as an Independent Non-Executive Director. With over 30 years of experience in the field of clinical psychology and substance use disorders, Dr. Humphreys is one of the leading minds in the substance abuse space and his research addresses addictive disorders and translation of science into public policy. He will be a tremendous asset as we continue to focus on our purpose of bringing science-based, life-transforming treatments to patients,” said Board chair, Graham Hetherington.
Dr. Humphreys has also joined the Compliance, Ethics & Sustainability, Nomination and Science Committees.
Dr. Tom McLellan will step down from the Board effective from February 29, 2024.
About Dr. Keith Humphreys
Dr. Humphreys is an Esther Ting Memorial Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University. He was previously a Senior Policy Advisor in the White House Office of National Drug Control Policy in the Obama Administration and is an Honorary Professor of Psychiatry at the Institute of Psychiatry, King’s College, London. Dr. Humphreys was awarded an OBE in September 2022 for his services to science and policy on addiction.
About Indivior
Indivior is a global pharmaceutical company working to help change patients’ lives by developing medicines to treat addiction and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for chronic conditions and co-occurring disorders of substance use disorder. Indivior is dedicated to transforming SUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of SUD, including alcohol use disorder and cannabis use disorder. Headquartered in the United States in Richmond, VA, Indivior employs more than 1,000 individuals globally and its portfolio of products is available in 37 countries worldwide.
SOURCE: https://www.indivior.com/en
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.